Skip to content

PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery

PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05359887
Acronym
ObesiPET
Enrollment
30
Registered
2022-05-04
Start date
2022-12-01
Completion date
2026-12-31
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Reward system, PET-scan, [11C]-Raclopride

Brief summary

Bariatric surgery (BS) is currently the most effective treatment in severe obesity. However, a considerable percentage of patients undergoing BS fail to lose sufficient weight or regain weight after initial weight loss during long-term follow-up, which may be attributed to personality traits and pathological eating behaviour. Previous positron emission tomography (PET) studies have shown reduced dopamine D2 receptor availability in obese patients and upregulation of this availability following successful BS in the brain's reward system. Dopamine D2 receptor availability in patients with unsuccessful BS has not been investigated to date.

Interventions

Administration of food in controlled situation

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bariatric surgery 24-36 months prior to the study * Adult (over 18y old) * Mentally capable to understand the consequences of the procedure and make his or her own choice without coercion * Able to undergo PET and MRI, according to the investigator's assessment * Native speaking * Able to participate in follow-up * Written informed consent

Exclusion criteria

* Presence of a DSM-IV axis 1 disorder * The use of drugs that bind to dopamine D2/3 receptors, including various classes of antipsychotics and antidepressants * History of stroke, brain tumor, Parkinson's Disease or dementia * History of head trauma with loss of consciousness * Alcohol or substance abuse in the last 6 months * Alcohol consumption 24h prior to PET scanning * Smoking or other forms of nicotine intake 12 hours prior to PET scanning * Use of anorectic drugs in the last 6 months * Current pregnancy * Medication for Diabetes Mellitus * Claustrophobia * The presence of implanted metal objects of the type which may concentrate radiofrequency fields or cause tissue damage from twisting in a magnetic field (such as certain implanted devices, shrapnel, ocular metal shavings) * Patients with a bodyweight \> 200kg will be excluded to ensure the maximum load of the camera bed of the PET-scanner (227 kg) is not exceeded.

Design outcomes

Primary

MeasureTime frameDescription
Change in [11C]-raclopride binding potential in the brain's reward system between study groups before and after a food challenge.-50 minutes (before start of PET scanning), 0 minutes (during PET break, before mixed meal), 30 minutes (after second phase of PET-scanning)Pre- and post-eating changes in dopamine D2 receptor availability as indexed by the \[11C\]-raclopride binding potential in the brain's reward system between subjects who underwent successful vs unsuccessful bariatric surgery

Secondary

MeasureTime frameDescription
The correlation between [11C]-raclopride binding potential in the brain's reward system and of questionnaires and diariesPre-interventionThe correlation between questionnaires on eating habits (EDE-Q, REO, YFAS) and quality of life (OBESI-Q) in patients who had successful vs unsuccessful BS and \[11C\]-raclopride binding potential.
The correlation between [11C]-raclopride binding potential in the brain's reward system and of gut hormones.-50 minutes (before start of PET scanning), 0 minutes (during PET break, before mixed meal), 30 minutes (after second phase of PET-scanning), 60 - 90 - 120 minutesThe relation between fasting or fed (gut) hormone concentrations and dopamine D2 receptor availability in the reward system.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026